These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 27751872

  • 1. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity.
    Plani-Lam JH, Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Singer P, Lam KP, Hibbs ML, Ingley E.
    Exp Hematol; 2017 Feb; 46():70-82.e10. PubMed ID: 27751872
    [Abstract] [Full Text] [Related]

  • 2. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, Stone L, McCarthy DJ, Klinken SP, Hibbs ML, Ingley E.
    Biochem J; 2014 May 01; 459(3):455-66. PubMed ID: 24552351
    [Abstract] [Full Text] [Related]

  • 3. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
    Slavova-Azmanova NS, Kucera N, Satiaputra J, Stone L, Magno A, Maxwell MJ, Quilici C, Erber W, Klinken SP, Hibbs ML, Ingley E.
    Blood; 2013 Jul 11; 122(2):262-71. PubMed ID: 23692855
    [Abstract] [Full Text] [Related]

  • 4. Csk-binding protein can regulate Lyn signals controlling cell morphology.
    Ingley E.
    Int J Biochem Cell Biol; 2009 Jun 11; 41(6):1332-43. PubMed ID: 19124084
    [Abstract] [Full Text] [Related]

  • 5. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
    Potuckova L, Draberova L, Halova I, Paulenda T, Draber P.
    Front Immunol; 2018 Jun 11; 9():1771. PubMed ID: 30116247
    [Abstract] [Full Text] [Related]

  • 6. Csk-binding protein mediates sequential enzymatic down-regulation and degradation of Lyn in erythropoietin-stimulated cells.
    Ingley E, Schneider JR, Payne CJ, McCarthy DJ, Harder KW, Hibbs ML, Klinken SP.
    J Biol Chem; 2006 Oct 20; 281(42):31920-9. PubMed ID: 16920712
    [Abstract] [Full Text] [Related]

  • 7. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.
    Cancer Res; 2001 Mar 15; 61(6):2453-8. PubMed ID: 11289114
    [Abstract] [Full Text] [Related]

  • 8. Integrating novel signaling pathways involved in erythropoiesis.
    Ingley E.
    IUBMB Life; 2012 May 15; 64(5):402-10. PubMed ID: 22431075
    [Abstract] [Full Text] [Related]

  • 9. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
    Zhu QS, Robinson LJ, Roginskaya V, Corey SJ.
    Blood; 2004 May 01; 103(9):3305-12. PubMed ID: 14656892
    [Abstract] [Full Text] [Related]

  • 10. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
    Whiting RJ, Payne CJ, Satiaputra J, Kucera N, Qiu TW, Irtegun S, Gunn NJ, Slavova-Azmanova NS, Mulhern TD, Ingley E.
    Biochem J; 2012 Mar 15; 442(3):611-20. PubMed ID: 22364282
    [Abstract] [Full Text] [Related]

  • 11. Src family kinases: regulation of their activities, levels and identification of new pathways.
    Ingley E.
    Biochim Biophys Acta; 2008 Jan 15; 1784(1):56-65. PubMed ID: 17905674
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cutting Edge: Transmembrane phosphoprotein Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomains as a negative feedback regulator of mast cell signaling through the FcepsilonRI.
    Ohtake H, Ichikawa N, Okada M, Yamashita T.
    J Immunol; 2002 Mar 01; 168(5):2087-90. PubMed ID: 11859092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phosphatidylinositol-3 kinase activity in B cells is negatively regulated by Lyn tyrosine kinase.
    Xu Y, Huntington ND, Harder KW, Nandurkar H, Hibbs ML, Tarlinton DM.
    Immunol Cell Biol; 2012 Oct 01; 90(9):903-11. PubMed ID: 22777522
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function.
    Dobenecker MW, Schmedt C, Okada M, Tarakhovsky A.
    Mol Cell Biol; 2005 Dec 01; 25(23):10533-42. PubMed ID: 16287865
    [Abstract] [Full Text] [Related]

  • 19. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ, Feng X, Zhou W, Knyazev PG, Ullrich A, Chen Z.
    Oncogene; 2006 Sep 07; 25(40):5495-506. PubMed ID: 16636672
    [Abstract] [Full Text] [Related]

  • 20. CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn.
    Harashima A, Suzuki M, Okochi A, Yamamoto M, Matsuo Y, Motoda R, Yoshioka T, Orita K.
    Blood; 2002 Dec 15; 100(13):4440-5. PubMed ID: 12393728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.